Alliance Defending Freedom
Alliance Defending Freedom
Erik Baptist serves as senior counsel at Alliance Defending Freedom, focusing on administrative litigation and regulatory advocacy.
Before joining ADF, Baptist was a partner at Wiley Rein LLP—one of the largest law firms in Washington, D.C.—where he employed his expertise in administrative and environmental law to represent clients on litigation, regulatory, and enforcement matters.
Prior to working at Wiley, Baptist served as a senior executive service appointee at the U.S. Environmental Protection Agency. As the senior deputy general counsel and deputy assistant administrator, he directed EPA’s litigation, implemented groundbreaking rulemakings and policies, represented EPA and defended witnesses in response to congressional inquiries, and collectively helped oversee the work of more than 1,100 EPA lawyers, scientists, and staff.
Baptist began his career in the Trial Department of the international law firm McDermott, Will & Emery LLP. He earned his B.A. from Vanderbilt University and his J.D. from The George Washington University Law School. During law school, Baptist externed for the Honorable Ricardo M. Urbina of the U.S. District Court for the District of Columbia, interned for the Honorable Eric T. Washington of the D.C. Court of Appeals, and served on The George Washington International Law Review.
Baptist is an active member of the D.C. Bar and is admitted to practice before the U.S. Supreme Court and various federal courts of appeal.
A person listed as a contributor has spoken or otherwise participated in Regulatory Transparency Project events, publications, or multimedia presentations. A person's appearance on the website does not imply an endorsement or relationship between the person and the Regulatory Transparency Project. The Regulatory Transparency Project takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.
Deep Dive Episode 253 – Litigation Update: AHM v. FDA: Challenging the FDA on “Chemical Abortion Drugs”
In November 2022, the Alliance Defending Freedom (ADF) filed a federal lawsuit against the FDA on behalf of the AHM and others, challenging the FDA’s 2000 decision to legalize mifepristone and misoprostol, two drugs often used in conjunction as chemical abortifacients.Listen to this podcast
Litigation Update: AHM v. FDA: Challenging the FDA on “Chemical Abortion Drugs”
In November 2022, the Alliance Defending Freedom (ADF) filed a federal lawsuit in the U.S. District Court for the Northern District of Texas, Amarillo Division, against the United States Food and Drug Administration (FDA) on behalf of the Alliance of Hippocratic Medicine (AHM) and others.Watch this video